ICIs quick Flashcards by Raphaella Ridley

Q

Waterhouse 95

A

ctla4 ko

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Leach 96

A

anti ctla ab tumour rej

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

hodi 2010

A

pIII antictla4 ab plateau

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

robert 11

A

I+D or D+P pIII trial

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Robert 15

A

N vs D

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Larkin 2015

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Alexandrov 13

A

TMB

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Snyder 2014

A

high fitness neoantigens

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Marabelle 2020

A

clin trial high tmb = high survival

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Gurajao 2020

A

preprint

small no. tumour types and wrong FDA cut-off

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Le 2015

A

MMRd

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Zaretsky 2016

A

specific jak mutations

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Chowell 2018

A

pt germline gen

HLA-I het

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

ttopalian 2012

A

PD1 ex as pred of pt resp

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Sunshine and Taube 2015

A

PD1 not a good marker

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Tumeh 2014

A

TIL densty

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

De Henau 2016

A

MDSCs and Pi3Ky inhibitors

Q

Matson 2018

A

microbiota

Q

Papadopoulos 2019

A

LAG-3

Q

Ribas 2017

A

oncolytic virus

Q

Valero 20211

A

N:L ratio

Q

ctla4 ko

A

Waterhouse 95

Q

anti ctla ab tumour rej

A

Leach 96

Q

pIII antictla4 ab plateau

A

hodi 2010

Q

I+D or D+P pIII trial

A

robert 11

Q

N vs D

A

Robert 15

Q

COMB

A

Larkin 2015

Q

TMB

A

Alexandrov 13

Q

high fitness neoantigens

A

Snyder 2014

Q

clin trial high tmb = high survival

A

Marabelle 2020

Q

preprint

small no. tumour types and wrong FDA cut-off

A

Gurajao 2020

Q

MMRd

A

Le 2015

Q

specific jak mutations

A

Zaretsky 2016

Q

pt germline gen

HLA-I het

A

Chowell 2018

Q

PD1 ex as pred of pt resp

A

ttopalian 2012

Q

PD1 not a good marker

A

Sunshine and Taube 2015

Q

TIL densty

A

Tumeh 2014

Q

MDSCs and Pi3Ky inhibitors

A

De Henau 2016

Q

microbiota

A

Matson 2018

Q

LAG-3

A

Papadopoulos 2019

Q

oncolytic virus

A

Ribas 2017

Q

N:L ratio

A

Valero 20211